Nanoengineered drug delivery in cancer immunotherapy for overcoming immunosuppressive tumor microenvironment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoengineered drug delivery in cancer immunotherapy for overcoming immunosuppressive tumor microenvironment
Authors
Keywords
-
Journal
Drug Delivery and Translational Research
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-30
DOI
10.1007/s13346-022-01282-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
- (2022) Nisha Kumari et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy
- (2022) Bhalchandra Mirlekar SAGE Open Medicine
- Arginase: An emerging and promising therapeutic target for cancer treatment
- (2022) Fanglin Niu et al. BIOMEDICINE & PHARMACOTHERAPY
- Multifunctional metal-organic framework-based nanoreactor for starvation/oxidation improved indoleamine 2,3-dioxygenase-blockade tumor immunotherapy
- (2022) Liangliang Dai et al. Nature Communications
- Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy
- (2022) Hans Raskov et al. Oncogenesis
- Inhibition of myeloid-derived suppressor cell arginase-1 production enhances T-cell-based immunotherapy against Cryptococcus neoformans infection
- (2022) Ya-Nan Li et al. Nature Communications
- OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer
- (2022) Marcin Mikołaj Grzybowski et al. Cancers
- Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil Granulocytes
- (2021) Verena Vonwirth et al. Frontiers in Immunology
- Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Escherichia coli Combined with Immunogenic Cell Death for Cancer Immunotherapy
- (2021) Baicheng Wei et al. NANO LETTERS
- Supramolecular Tadalafil Nanovaccine for Cancer Immunotherapy by Alleviating Myeloid‐Derived Suppressor Cells and Heightening Immunogenicity
- (2021) Tian Zhang et al. Small Methods
- Tumor-Associated Macrophages—Implications for Molecular Oncology and Imaging
- (2021) Melanie A. Kimm et al. Biomedicines
- Ataxia telangiectasia mutated inhibitor-loaded copper sulfide nanoparticles for low-temperature photothermal therapy of hepatocellular carcinoma
- (2021) Hongqiao Cai et al. Acta Biomaterialia
- Macrophage Polarization States in the Tumor Microenvironment
- (2021) Ava J. Boutilier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Macrophages as a “weapon” in anticancer cellular immunotherapy
- (2021) Dmitry Aminin et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology
- (2021) Min Lu et al. ACS Medicinal Chemistry Letters
- Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
- (2021) Seung Mo Jin et al. Advanced Science
- The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
- (2020) Alexandra Schnell et al. CELL RESEARCH
- Manipulation of the Innate Immune Response by Varicella Zoster Virus
- (2020) Chelsea Gerada et al. Frontiers in Immunology
- Reverting Immune Suppression to Enhance Cancer Immunotherapy
- (2020) Bella S. Guerrouahen et al. Frontiers in Oncology
- Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
- (2020) Bo Sun et al. ACTA PHARMACOLOGICA SINICA
- Cytokines that target immune killer cells against tumors
- (2020) Jian Qiao et al. Cellular & Molecular Immunology
- Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective
- (2020) Gonçalo S. Clemente et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modulation of Inflammation-Induced Tolerance in Cancer
- (2020) Vladimir Rogovskii Frontiers in Immunology
- Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies
- (2020) Lijie Zhai et al. Frontiers in Immunology
- Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity
- (2020) Won Suk Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- IDO Expression in Cancer: Different Compartment, Different Functionality?
- (2020) Annabel Meireson et al. Frontiers in Immunology
- CD25-targeted antibody–drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity
- (2020) Francesca Zammarchi et al. Journal for ImmunoTherapy of Cancer
- New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression
- (2020) Norihisa Mikami et al. CURRENT OPINION IN IMMUNOLOGY
- Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy
- (2020) Sundee Dees et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Understanding the tumor microenvironment for effective immunotherapy
- (2020) Habib Sadeghi Rad et al. MEDICINAL RESEARCH REVIEWS
- Tumor-Associated Macrophages in Tumor Immunity
- (2020) Yueyun Pan et al. Frontiers in Immunology
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model
- (2019) Jamile R. Silva et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
- (2019) Malgorzata Czystowska-Kuzmicz et al. Nature Communications
- TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
- (2018) Lan Huang et al. Cellular & Molecular Immunology
- Co-delivery nanoparticle to overcome metastasis promoted by insufficient chemotherapy
- (2018) Qing Zhou et al. JOURNAL OF CONTROLLED RELEASE
- Immunomodulatory capacity of the serotonin receptor 5-HT2B in a subset of human dendritic cells
- (2018) Attila Szabo et al. Scientific Reports
- Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
- (2018) Kulmira Nurgali et al. Frontiers in Pharmacology
- Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers
- (2018) Limei Shen et al. ACS Nano
- Understanding the tumour microenvironment communication network from a NOS2/COX2 perspective
- (2018) Debashree Basudhar et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cytokines in clinical cancer immunotherapy
- (2018) Pedro Berraondo et al. BRITISH JOURNAL OF CANCER
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Regulation of iNOS on Immune Cells and Its Role in Diseases
- (2018) Qingjie Xue et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
- (2017) Susanne M. Steggerda et al. Journal for ImmunoTherapy of Cancer
- Nanotherapeutics to Overcome Conventional Cancer Chemotherapy Limitations
- (2016) Moorthi Chidambaram et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Tissue resident regulatory T cells: novel therapeutic targets for human disease
- (2015) Xiaohui Zhou et al. Cellular & Molecular Immunology
- Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model
- (2015) Hiroyasu Ito et al. IMMUNOLOGY
- IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1
- (2015) Peter Hsu et al. JOURNAL OF IMMUNOLOGY
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- The dual role of iNOS in cancer
- (2015) Federica Vannini et al. Redox Biology
- Epistemology of the origin of cancer: a new paradigm
- (2014) Björn LDM Brücher et al. BMC CANCER
- Harnessing the antitumor potential of macrophages for cancer immunotherapy
- (2014) Kristen B Long et al. OncoImmunology
- Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model
- (2014) Rikke B Holmgaard et al. Journal for ImmunoTherapy of Cancer
- The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
- (2012) Dennis Lindau et al. IMMUNOLOGY
- IDO Induces Expression of a Novel Tryptophan Transporter in Mouse and Human Tumor Cells
- (2011) J. D. Silk et al. JOURNAL OF IMMUNOLOGY
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma
- (2010) L H L Marchi et al. CANCER GENE THERAPY
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Advanced Colorectal Cancer Is Associated With Enhanced IL-23 and IL-10 Serum Levels
- (2010) Noyko Stanilov et al. Labmedicine
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- Arginase: an emerging key player in the mammalian immune system
- (2009) Markus Munder BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started